Accendra Health Inc
ACH· NYSE
ACHAccendra Health Inc
Quarterly figures for Accendra Health Inc, with source filings when available.
69 quarters. Jun 30, 2009 to Jun 30, 2026. USD.
Accendra Health Inc has filed its 10-Q within 31 to 42 days of period end across its last 8 quarters. The 10-K runs 51 to 65 days.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 10, 2026 · pre-market | Aug 10, 2026 | 41 d | 10-Q | $613.23M | −10.1% | -$1.16 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 11, 2026 · pre-market |
| May 11, 2026 |
| 41 d |
| 10-Q |
| $627.78M |
| −6.8% |
| -$0.08 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Feb 19, 2026 · after-hours | Feb 20, 2026 | 51 d | 10-K | $708.97M | — | — | |
| Q3 2025 | Sep 30, 2025 | Oct 30, 2025 · after-hours | Oct 31, 2025 | 31 d | 10-Q | $697.26M | +1.5% | -$1.94 | |
| Q2 2025 | Jun 30, 2025 | Aug 11, 2025 · pre-market | Aug 11, 2025 | 42 d | 10-Q | $681.92M | +3.3% | -$11.30 | |
| Q1 2025 | Mar 31, 2025 | May 8, 2025 · pre-market | May 8, 2025 | 38 d | 10-Q | $673.88M | −74.2% | -$0.32 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Feb 28, 2025 · pre-market | Feb 28, 2025 | 59 d | 10-K | — | — | — | |
| Q3 2024 | Sep 30, 2024 | Nov 4, 2024 · pre-market | Nov 4, 2024 | 35 d | 10-Q | $686.85M | −73.5% | -$0.16 | |
| Q2 2024 | Jun 30, 2024 | Aug 2, 2024 · pre-market | Aug 2, 2024 | 33 d | 10-Q | $660.40M | −74.2% | -$0.42 | |
| Q1 2024 | Mar 31, 2024 | May 3, 2024 · pre-market | May 3, 2024 | 33 d | 10-Q | $2.61B | +3.6% | -$0.29 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Feb 20, 2024 · pre-market | Feb 20, 2024 | 51 d | 10-K | — | — | — | |
| Q3 2023 | Sep 30, 2023 | Nov 3, 2023 · pre-market | Nov 3, 2023 | 34 d | 10-Q | $2.59B | +3.8% | -$0.08 | |
| Q2 2023 | Jun 30, 2023 | Aug 4, 2023 · pre-market | Aug 4, 2023 | 35 d | 10-Q | $2.56B | +2.5% | -$0.37 | |
| Q1 2023 | Mar 31, 2023 | May 5, 2023 · pre-market | May 5, 2023 | 35 d | 10-Q | $2.52B | +4.8% | -$0.32 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Feb 28, 2023 · pre-market | Feb 28, 2023 | 59 d | 10-K | $2.55B | +3.4% | — | |
| Q3 2022 | Sep 30, 2022 | Nov 2, 2022 · pre-market | Nov 2, 2022 | 33 d | 10-Q | $2.50B | −0.2% | $0.16 | |
| Q2 2022 | Jun 30, 2022 | Aug 3, 2022 · pre-market | Aug 3, 2022 | 34 d | 10-Q | $2.50B | +0.4% | $0.37 | |
| Q1 2022 | Mar 31, 2022 | May 3, 2022 · after-hours | May 4, 2022 | 34 d | 10-Q | $2.41B | +3.5% | $0.52 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Feb 23, 2022 · pre-market | Feb 23, 2022 | 54 d | 10-K | $2.47B | +4.5% | — | |
| Q3 2021 | Sep 30, 2021 | Nov 3, 2021 · pre-market | Nov 3, 2021 | 34 d | 10-Q | $2.50B | +14.4% | $0.58 | |
| Q2 2021 | Jun 30, 2021 | Aug 3, 2021 · pre-market | Aug 3, 2021 | 34 d | 10-Q | $2.49B | +37.7% | $0.87 | |
| Q1 2021 | Mar 31, 2021 | May 5, 2021 · pre-market | May 5, 2021 | 35 d | 10-Q | $2.33B | +9.6% | $0.98 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | Feb 24, 2021 · pre-market | Feb 24, 2021 | 55 d | 10-K | $2.36B | +7.8% | — | |
| Q3 2020 | Sep 30, 2020 | Nov 2, 2020 · after-hours | Nov 3, 2020 | 34 d | 10-Q | $2.19B | −4.6% | $0.76 | |
| Q2 2020 | Jun 30, 2020 | Aug 4, 2020 · after-hours | Aug 5, 2020 | 36 d | 10-Q | $1.81B | −23.9% | -$0.91 | |
| Q1 2020 | Mar 31, 2020 | May 6, 2020 · pre-market | May 6, 2020 | 36 d | 10-Q | $2.12B | −9.7% | -$0.19 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019derived | Dec 31, 2019 | Mar 4, 2020 · pre-market | Mar 4, 2020 | 64 d | 10-K | $2.19B | +3.2% | — | |
| Q3 2019 | Sep 30, 2019 | Nov 6, 2019 · pre-market | Nov 6, 2019 | 37 d | 10-Q | $2.29B | −7.0% | $0.02 | |
| Q2 2019 | Jun 30, 2019 | Aug 7, 2019 · pre-market | Aug 7, 2019 | 38 d | 10-Q | $2.38B | −3.3% | -$0.17 | |
| Q1 2019 | Mar 31, 2019 | May 7, 2019 · pre-market | May 7, 2019 | 37 d | 10-Q | $2.35B | −0.9% | -$0.23 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018derived | Dec 31, 2018 | Feb 19, 2019 · after-hours | Mar 6, 2019 | 65 d | 10-K | $2.12B | −11.2% | — | |
| Q3 2018 | Sep 30, 2018 | Oct 31, 2018 · pre-market | Nov 5, 2018 | 36 d | 10-Q | $2.46B | +5.6% | -$0.01 | |
| Q2 2018 | Jun 30, 2018 | Aug 7, 2018 · pre-market | Aug 8, 2018 | 39 d | 10-Q | $2.46B | +8.5% | -$3.07 | |
| Q1 2018 | Mar 31, 2018 | May 10, 2018 · pre-market | May 10, 2018 | 40 d | 10-Q | $2.37B | +1.9% | $0.13 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017derived | Dec 31, 2017 | — | Feb 23, 2018 | 54 d | 10-K | $2.39B | +0.9% | — | |
| Q3 2017 | Sep 30, 2017 | — | Nov 2, 2017 | 33 d | 10-Q | $2.33B | −3.4% | $0.18 | |
| Q2 2017 | Jun 30, 2017 | — | Aug 2, 2017 | 33 d | 10-Q | $2.27B | −8.8% | $0.33 | |
| Q1 2017 | Mar 31, 2017 | — | May 3, 2017 | 33 d | 10-Q | $2.33B | −5.2% | $0.31 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016derived | Dec 31, 2016 | — | — | — | — | $2.37B | −4.8% | — | |
| Q3 2016 | Sep 30, 2016 | — | — | — | — | $2.42B | −2.3% | $0.48 | |
| Q2 2016 | Jun 30, 2016 | — | — | — | — | $2.48B | +2.5% | $0.45 | |
| Q1 2016 | Mar 31, 2016 | — | — | — | — | $2.46B | +2.7% | $0.39 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015derived | Dec 31, 2015 | — | — | — | — | $2.49B | −0.2% | — | |
| Q3 2015 | Sep 30, 2015 | — | — | — | — | $2.47B | +3.6% | $0.45 | |
| Q2 2015 | Jun 30, 2015 | — | — | — | — | $2.42B | +5.0% | $0.39 | |
| Q1 2015 | Mar 31, 2015 | — | — | — | — | $2.39B | +6.0% | $0.30 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014derived | Dec 31, 2014 | — | — | — | — | $2.49B | +7.5% | — | |
| Q3 2014 | Sep 30, 2014 | — | — | — | — | $2.39B | +5.1% | $0.11 | |
| Q2 2014 | Jun 30, 2014 | — | — | — | — | $2.31B | +3.1% | $0.32 | |
| Q1 2014 | Mar 31, 2014 | — | — | — | — | $2.26B | +0.4% | $0.41 | |
| FY 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2013derived | Dec 31, 2013 | — | — | — | — | $2.32B | +1.5% | — | |
| Q3 2013 | Sep 30, 2013 | — | — | — | — | $2.27B | +4.2% | $0.44 | |
| Q2 2013 | Jun 30, 2013 | — | — | — | — | $2.24B | +2.3% | $0.46 | |
| Q1 2013 | Mar 31, 2013 | — | May 3, 2013 | 33 d | 10-Q | $2.25B | +1.3% | $0.41 | |
| FY 2012 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2012derived | Dec 31, 2012 | — | — | — | — | $2.29B | +4.1% | — | |
| Q3 2012 | Sep 30, 2012 | — | — | — | — | $2.18B | +0.1% | $0.39 | |
| Q2 2012 | Jun 30, 2012 | — | Jul 27, 2012 | 27 d | 10-Q | $2.19B | +2.5% | $0.48 | |
| Q1 2012 | Mar 31, 2012 | — | Apr 27, 2012 | 27 d | 10-Q | $2.22B | +4.4% | $0.46 | |
| FY 2011 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2011derived | Dec 31, 2011 | — | — | — | — | $2.20B | +6.1% | — | |
| Q3 2011 | Sep 30, 2011 | — | Oct 28, 2011 | 28 d | 10-Q | $2.18B | +5.5% | $0.53 | |
| Q2 2011 | Jun 30, 2011 | — | — | — | — | $2.13B | +5.5% | $0.46 | |
| Q1 2011 | Mar 31, 2011 | — | — | — | — | $2.12B | +7.8% | $0.45 | |
| FY 2010 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2010derived | Dec 31, 2010 | — | — | — | — | $2.07B | — | — | |
| Q3 2010 | Sep 30, 2010 | — | — | — | — | $2.06B | +1.4% | $0.50 | |
| Q2 2010 | Jun 30, 2010 | — | — | — | — | $2.02B | +0.3% | $0.46 | |
| Q1 2010 | Mar 31, 2010 | — | — | — | — | $1.97B | — | $0.44 | |
| FY 2009 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2009derived | Dec 31, 2009 | — | — | — | — | — | — | — | |
| Q3 2009 | Sep 30, 2009 | — | — | — | — | $2.03B | — | $0.55 | |
| Q2 2009 | Jun 30, 2009 | — | — | — | — | $2.01B | — | $0.38 | |
